HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maurizio Martini Selected Research

Biological Products

3/2012Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome.
5/2011The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.
7/2009Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.
10/2008Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maurizio Martini Research Topics

Disease

65Neoplasms (Cancer)
06/2022 - 12/2002
23Glioblastoma (Glioblastoma Multiforme)
04/2022 - 12/2008
9Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 12/2011
6Prostatic Neoplasms (Prostate Cancer)
12/2022 - 02/2011
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 01/2002
6Sarcoma (Soft Tissue Sarcoma)
01/2019 - 06/2013
6Papillary Thyroid Cancer
01/2019 - 06/2013
5Carcinoma (Carcinomatosis)
01/2022 - 03/2012
5Neoplasm Metastasis (Metastasis)
12/2021 - 03/2015
5Glioma (Gliomas)
01/2021 - 12/2011
5Hodgkin Disease (Hodgkin's Disease)
01/2018 - 03/2008
5Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2013 - 03/2007
4Squamous Cell Carcinoma of Head and Neck
02/2022 - 01/2021
4Adenocarcinoma
01/2021 - 05/2017
4Disease Progression
01/2021 - 12/2008
3Ependymoma
02/2021 - 11/2017
3Carcinogenesis
01/2021 - 01/2017
3Inflammation (Inflammations)
01/2021 - 11/2007
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 02/2016
3Non-alcoholic Fatty Liver Disease
01/2021 - 02/2018
3Hemorrhage
11/2020 - 01/2013
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2019 - 07/2004
3Thrombocytosis (Thrombocythemia)
03/2012 - 10/2002
3Polycythemia (Erythrocytosis)
03/2012 - 10/2002
3Lymphoma (Lymphomas)
07/2009 - 03/2007
3Essential Thrombocythemia
10/2008 - 10/2002
3Polycythemia Vera
10/2008 - 10/2002
2Thyroid Neoplasms (Thyroid Cancer)
06/2022 - 05/2017
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 02/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 06/2016
2Hypoxia (Hypoxemia)
05/2020 - 07/2008
2Brain Neoplasms (Brain Tumor)
01/2018 - 01/2017
2Hyperplasia
05/2017 - 02/2011
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2016 - 08/2008
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2014 - 09/2006
2Infections
03/2013 - 02/2013
2Acquired Immunodeficiency Syndrome (AIDS)
03/2007 - 01/2002
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Non-Muscle Invasive Bladder Neoplasms
01/2022
1Splenomegaly
12/2021

Drug/Important Bio-Agent (IBA)

11Biomarkers (Surrogate Marker)IBA
06/2022 - 07/2014
9Messenger RNA (mRNA)IBA
01/2021 - 07/2008
9DNA (Deoxyribonucleic Acid)IBA
01/2019 - 03/2007
8ErbB Receptors (EGF Receptor)IBA
04/2022 - 12/2011
8Proteins (Proteins, Gene)FDA Link
02/2021 - 12/2002
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 07/2008
5epidermal growth factor receptor VIIIIBA
04/2022 - 12/2011
5MicroRNAs (MicroRNA)IBA
05/2020 - 11/2015
5Bevacizumab (Avastin)FDA Link
01/2019 - 01/2013
5EnzymesIBA
01/2019 - 03/2007
5CytokinesIBA
05/2017 - 03/2008
4B7-H1 AntigenIBA
06/2022 - 01/2020
4Temozolomide (Temodar)FDA LinkGeneric
01/2019 - 12/2008
4Biological ProductsIBA
03/2012 - 10/2008
3AntibodiesIBA
02/2022 - 04/2014
3Cetuximab (Erbitux)FDA Link
12/2021 - 12/2011
3Pharmaceutical PreparationsIBA
02/2021 - 01/2015
3Tyrosine Kinase InhibitorsIBA
01/2021 - 02/2016
3RNA (Ribonucleic Acid)IBA
01/2021 - 03/2007
3Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2019 - 01/2013
3Monoclonal AntibodiesIBA
01/2019 - 10/2017
3Glutamic Acid (Glutamate)FDA Link
10/2015 - 06/2013
3Valine (L-Valine)FDA Link
10/2015 - 06/2013
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2007 - 10/2002
2Formaldehyde (Formol)FDA Link
02/2022 - 01/2019
2ParaffinIBA
02/2022 - 01/2019
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2022 - 01/2002
2Histones (Histone)IBA
02/2021 - 09/2012
2Chromogranin AIBA
01/2021 - 07/2016
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 01/2019
2SynaptophysinIBA
01/2021 - 07/2016
2Phosphotransferases (Kinase)IBA
01/2021 - 07/2013
2RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021 - 01/2013
2Long Noncoding RNAIBA
12/2020 - 05/2020
2LuciferasesIBA
05/2020 - 03/2012
2MART-1 AntigenIBA
04/2020 - 07/2016
2ChromatinIBA
02/2020 - 09/2018
2Androgen Receptors (Androgen Receptor)IBA
01/2020 - 03/2007
2Immunoglobulins (Immunoglobulin)IBA
01/2020 - 08/2008
2Anaplastic Lymphoma KinaseIBA
07/2018 - 07/2016
2Protein Isoforms (Isoforms)IBA
05/2018 - 05/2015
2Suppressor of Cytokine Signaling 3 ProteinIBA
05/2018 - 05/2017
2Epidermal Growth Factor (EGF)IBA
11/2017 - 12/2011
2Galectin 3 (LGALS3)IBA
01/2013 - 12/2012
2Interleukin-6 (Interleukin 6)IBA
03/2012 - 02/2011
2Cyclin-Dependent Kinase Inhibitor p16IBA
07/2004 - 12/2002
1LigandsIBA
01/2022
1Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2021
1encorafenibIBA
12/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021
1elesclomolIBA
07/2021

Therapy/Procedure

26Therapeutics
06/2022 - 01/2013
8Drug Therapy (Chemotherapy)
01/2022 - 12/2011
7Immunotherapy
06/2022 - 07/2018
7Radiotherapy
12/2020 - 12/2008
3Prostatectomy (Retropubic Prostatectomy)
12/2022 - 05/2017
2Orchiectomy (Orchidectomy)
01/2019 - 01/2019
1Cytoreduction Surgical Procedures
10/2021
1Hyperthermic Intraperitoneal Chemotherapy
10/2021